Karyopharm Therapeutics | 4:持股变动声明-高管 Paulson Richard A.
Karyopharm Therapeutics | 3:首次持股声明-高管 Abate Kristin
Karyopharm Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Avidity Partners Management LP(3.7%),Avidity Partners Management (GP) LLC(3.7%)等
Karyopharm Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-The Vanguard Group(6.13%)
Karyopharm Therapeutics | 4:持股变动声明-高管 Paulson Richard A.
Karyopharm Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-The Vanguard Group(6.13%)
Karyopharm Therapeutics | SC 13G:超过5%持股股东披露文件-Highbridge Capital Management, LLC(7.2%)
Karyopharm Therapeutics | 4:持股变动声明-高管 Paulson Richard A.
Karyopharm Therapeutics | 4:持股变动声明-高管 Mano Michael
Karyopharm Therapeutics | 4:持股变动声明-高管 Paulson Richard A.
Karyopharm Therapeutics | 4:持股变动声明-高管 Mason Michael
Karyopharm Therapeutics | 4:持股变动声明-高管 Cheng Sohanya Roshan
Karyopharm Therapeutics | 4:持股变动声明-高管 Paulson Richard A.
Karyopharm Therapeutics | 4:持股变动声明-高管 Poulton Stuart
Karyopharm Therapeutics | 4:持股变动声明-高管 Paulson Richard A.
Karyopharm Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-BlackRock, Inc.(3.5%)
Karyopharm Therapeutics | 4:持股变动声明-董事 PAKIANATHAN DEEPIKA
Karyopharm Therapeutics | 4:持股变动声明-高管 Mason Michael
Karyopharm Therapeutics | 4:持股变动声明-高管 Paulson Richard A.
Karyopharm Therapeutics | 4:持股变动声明-董事 PAKIANATHAN DEEPIKA